Drug-Target Information
Drug Name Target Name Drug Type Target Type Source Drug MeSHID Interaction Score Drug Status Target Action
sulodexide antithrombin-iii biotech Successful target TTD , drugbank , DGIDB Disease[MeSHID:D004194]
Veins[MeSHID:D014680]
Thrombosis[MeSHID:D013927]
Peripheral Arterial Diseases[MeSHID:D058729]
Peripheral Vascular Diseases[MeSHID:D016491]
Myocardium[MeSHID:D009206]
Diabetic Nephropathy[MeSHID:D003928]
Vascular Diseases[MeSHID:D014652]
Intermittent Claudication[MeSHID:D007383]
Diabetic Neuropathies[MeSHID:D003929]
Arterial Occlusive Diseases[MeSHID:D001157]
Disruptive
Impulse Control
and Conduct Disorders[MeSHID:D007174]
Tinnitus[MeSHID:D014012]		 7.64 approved,investigational potentiator
sulodexide heparin cofactor 2 biotech NA drugbank , DGIDB Disease[MeSHID:D004194]
Veins[MeSHID:D014680]
Thrombosis[MeSHID:D013927]
Peripheral Arterial Diseases[MeSHID:D058729]
Peripheral Vascular Diseases[MeSHID:D016491]
Myocardium[MeSHID:D009206]
Diabetic Nephropathy[MeSHID:D003928]
Vascular Diseases[MeSHID:D014652]
Intermittent Claudication[MeSHID:D007383]
Diabetic Neuropathies[MeSHID:D003929]
Arterial Occlusive Diseases[MeSHID:D001157]
Disruptive
Impulse Control
and Conduct Disorders[MeSHID:D007174]
Tinnitus[MeSHID:D014012]		 95.48 approved,investigational agonist
click here to return to the previous page